Navigation Links
11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
Date:12/4/2008

. Admittedly, this is perplexing to us for two reasons.

First, the Company's condition today is dire, its prognosis going forward poor. With the stock price decreasing approximately 90% since the Board appointed Steve Straus CEO in November 2006, the elimination of the quarterly dividend to shareholders, and the suspension of the share repurchase program, the status of the Company today from its recent successes tells a sad tale. So, too, do the Company's financial and operating results. Needless to say, dramatic losses in national market share and revenues plummeting 50% (which is well in excess of overall industry declines) are not typically associated with healthy companies. And with the Company burning approximately $2 million of cash per month, we can only assume that, like us, the Board is having its share of sleepless nights.

Second, we think the Board would be hard-pressed to find fault with our impeccable credentials in the laser vision correction industry generally, and with LCA-Vision specifically. It was under our leadership that LCA-Vision provided enviable returns to its shareholders well in excess of 1,000% from 2003-2006. It was under our leadership that the Company's physician partners and employees thrived, financially and professionally. It was under our leadership that the Company generated substantial free cash flow that was used to profitably open vision centers, pay quarterly dividends to the Company's shareholders, repurchase shares, and build a rock solid balance sheet.

So, (i) given the Company is in dire need of help and (ii) the three of us represent the very team that is uniquely positioned to provide such help, we realized there must be a disconnect somewhere along the way. Recognizing the Board may not feel it understands specifically how we can help, we thought it would be helpful to provide the necessary clarity.

The three of us believe we can add t
'/>"/>

SOURCE Steve Joffe
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. 11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
2. Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract
3. Senator Norm Coleman Praised for Leading Successful Effort to Derail $11.4 Million Minnesota Medicare Cuts
4. NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder
5. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
6. Barr Shareholders Approve Pending Teva Acquisition
7. Cord Blood America Posts Letter to Shareholders: New Administrations Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders
8. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
9. MaxLife Fund Corp. declares dividends to shareholders of Preferred Shares
10. Westaim terminates reorganization agreement and cancels shareholders meeting
11. GeneThera - CHANGING DIRECTIONS - an Update to Shareholders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Study found one more than doubled chances, while...Y, Nov. 23 (HealthDay News) -- Children whose moth... lead have more than double the risk of having att...her children, new research shows. , And with ex... having ADHD soared. Children whose mothers smoked...
(Date:11/23/2009)... ,, CARLSBAD,Calif.,Nov.23/PRNewswire-FirstC..., Iwouldliketostartbythankingyouforyourcontinuin...fulmomentsinourhistory.Wearetrulyattheendofthebegi...ryplatform,whichwebelieveaddressesmanyoftheissuesh...sispredicatedlargelyuponthesuccessofourflagshipdru...
(Date:11/23/2009)... ,, SANDIEGO,Calif.,Nov.23/PRNewswire-FirstC... )todayannouncedthatfourseniorexecutiveshavejoined...isdrivingthedevelopmentofitsobesityfranchise.Addit...adofGlobalRegulatoryAffairs;SuzanneMcDonald,Headof...M.D.,HeadofGlobalContraveProgram;andWhedyWang,Ph.D...
(Date:11/23/2009)... , Baptist Cardiovascular... Jackson, Miss., is proud to announce the addition...w to its latest advancement in the treatment of pa...s and clinicians breathe easier. , ... -- For heart failure patients suffering from flui...
(Date:11/23/2009)... ,, NORTHANDOVER,Mass.,Nov.23/PRNewswire/--T...fstressandanxiety.Oftenthesefeelings,bothpositivea...ng;andlet,sfaceit,therearelotsofopportunitiestodos...veonepieceofmom,sapplepie,buthowmanyofusstopthere?...fushavespentholidayseasonafterholidayseasontelling...
Breaking Medicine News(10 mins):Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 2Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 4Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 5Health News:Baptist Cardiovascular Services Introduces New Technology for Congestive Heart Failure Treatment 2Health News:Baptist Cardiovascular Services Introduces New Technology for Congestive Heart Failure Treatment 3Health News:Tis' the Season to Eat and Eat More! 2
....J., Dec. 9 Roche announced today that a total of...hemotherapy Xeloda(R),(capecitabine) have been acc...ast Cancer Symposium (SABCS) in San AntonioDecembe...o U.S. abstracts to be presented at the meeting co...
...itals adhere to trend in medicine favoring non-inv...ations , , LOUISVILLE, Colo., Dec. 9 The nat...he non-invasive, safe and technologically advanced...is an evidence-based standard of care recommended ...
...ndia, Dec. 9 Frost & Sullivan, a global growt...held Manufacturing Summit, hosted the India Manufa...a Palace, Bangalore. Instituted in 2004, the award...ieved and sustained manufacturing excellence throu...
... Voonami, Inc., a leading provide...solutions, announced today the opening of their fi...hnology Center in Orem, UT. Voonami also announce... power capacity of 300 watts per square foot. , ...
... The holidays are an extended per...l grief from the death of a child need support and...ends can make the holidays just a little gentler. ...ters blanketing the United States. , ...
... All Nursing Schools delves into ...ective nursing students and nurses looking to furt...ation career and school opportunities. , ...ucation not only provides nursing career advanceme...
Other Medicine News:Health News:Twenty New Abstracts on Oral Xeloda(R) (capecitabine) Featured at the 31st San Antonio Breast Cancer Symposium 2Health News:Twenty New Abstracts on Oral Xeloda(R) (capecitabine) Featured at the 31st San Antonio Breast Cancer Symposium 3Health News:Top Heart Programs Choose Safety of Medivance's Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia 2Health News:Top Heart Programs Choose Safety of Medivance's Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia 3Health News:Excellence in Supply Chain and Manufacturing Recognized at Frost & Sullivan's India Manufacturing Excellence Awards 2008 2Health News:Excellence in Supply Chain and Manufacturing Recognized at Frost & Sullivan's India Manufacturing Excellence Awards 2008 3Health News:Excellence in Supply Chain and Manufacturing Recognized at Frost & Sullivan's India Manufacturing Excellence Awards 2008 4Health News:Excellence in Supply Chain and Manufacturing Recognized at Frost & Sullivan's India Manufacturing Excellence Awards 2008 5Health News:Voonami, Inc. Announces Three New Adaptive Data Centers 2Health News:Ten Ways You Can Help a Family During the Holidays After a Child Dies 2Health News:All Nursing Schools Offers Continuing Education Resources 2Health News:All Nursing Schools Offers Continuing Education Resources 3
(Date:11/20/2009)... , , HARRISBURG, Pa., Nov. 20 /PRNewswir...gan providing free H1N1 flu shots to members of pr... the vaccine. ,, A total of 18 clinics are bein...urs are from 2 p.m. to 8 p.m. Hours on Saturday, N...2, the clinics will operate from 2 p.m. to 8 p.m. ...
(Date:11/20/2009)... , , NEW YORK, Nov. 20 /PRNewswire/ -...earch report is available in its catalogue. ,, ...ctive ,, http://www.reportlinker.com/p016437...e.html#utm_source=prnewswire&utm_medium=pr&...ttors are treated as an integral part of any resea...
(Date:11/20/2009)... , , NEW YORK, Nov. 20 /PRNewswire/ -...earch report is available in its catalogue. ,, ...2009 ,, http://www.reportlinker.com/p0164742...2009.html#utm_source=prnewswire&utm_medium=pr&... for Assisted Reproduction covers the U.S., 15 Cou...
Breaking Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2CDPHP Medicare Choices Expands Service Area Northward 59305 1CDPHP Medicare Choices Expands Service Area Northward 59305 2CDPHP Medicare Choices Expands Service Area Northward 59305 3Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 59303 1Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 59303 2Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 59303 3Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 59303 4Greenway Medical Technologies EHR Platform Continues to Lead Interoperability Efforts With Participation in Key Health IT Integration Showcases 59301 1Greenway Medical Technologies EHR Platform Continues to Lead Interoperability Efforts With Participation in Key Health IT Integration Showcases 59301 2Greenway Medical Technologies EHR Platform Continues to Lead Interoperability Efforts With Participation in Key Health IT Integration Showcases 59301 3Greenway Medical Technologies EHR Platform Continues to Lead Interoperability Efforts With Participation in Key Health IT Integration Showcases 59301 4
... Mass., Aug. 17 Indevus,Pharmaceuticals, Inc. (Na...,an approvable letter from the U.S. Food and Drug ...erile solution of valrubicin for intravesical,inst...for therapy of,bacillus Calmette-Guerin (BCG)-refr...der. VALSTAR was removed from the market in 2002 ...
...ug. 17 Dendreon Corporation,(Nasdaq: DNDN ) toda...study,of NEUVENGE, an investigational active cellu...ournal of Clinical Oncology. The article highlight... activity of NEUVENGE in,women with HER2/neu-posit.... "In addition to demonstrating that NEUVENGE was...
Other Medicine Technology:Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 2Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 3Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 4Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 2Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 3Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 4
...ection Properly manufactured radiation protective...r radiation. Our high quality frames and materials...zed weight. Our lenses are made of Schott RS-520 (...ds. Most Pulse Glasses are offered with lead impre...
...ned with the safety and comfort of the practitione...ed SF-6) leaded glass, the industry standard for r...rds, as set for optical clarity, visible light tra...r eyewear is protecting your eyes, it also helps y...
...ned with the safety and comfort of the practitione...ed SF-6) leaded glass, the industry standard for r...rds, as set for optical clarity, visible light tra...r eyewear is protecting your eyes, it also helps y...
...ned with the safety and comfort of the practitione...ed SF-6) leaded glass, the industry standard for r...rds, as set for optical clarity, visible light tra...r eyewear is protecting your eyes, it also helps y...
Medicine Products: